Medication info
Depo-M tablets (Metformin Hydrochloride)

Depo-M tablets (Metformin Hydrochloride)

Prescription medicationTabletOral
Ingredient · strength
Metformin Hydrochloride›500mg / 1 tablet
Manufacturer / importer
Donggu Bio Pharmaceutical Co., Ltd.
Appearance
White round film-coated tablet
Packaging
30 tablets/bottle, 500 tablets/bottle
Approval status
Active

MFDS item code 200401462 · Notified 2004.01.14 · Insurance code 657301180

Summary

Main use
Treatment of type 2 diabetes mellitus
Who takes it
Adults · Children
Adult dose
The dose should be determined individually based on drug efficacy and tolerability and should not exceed the recommended maximum daily dose. This medicine must be started at a low dose to reduce gastrointestinal adverse reactions and identify the minimum dose required for adequate glycemic control. Administer 500mg per dose, 2~3 times a day, with meals. Increase the dose gradually by 500mg each week; when administering up to 2000mg, the dose is usually divided into 2 doses, in the morning and evening. If administering more than 2000mg, divide the dose into 3 doses per day and take with meals; up to a maximum of 2550mg per day may be administered. At initiation of treatment and during dose adjustment, measure fasting blood glucose to assess the response to this medicine and determine the minimum effective dose. Measure blood glycated hemoglobin approximately every 3 months. The goal of treatment with this medicine, whether administered as monotherapy or in combination with a sulfonylurea or insulin, is to reduce fasting blood glucose and blood glycated hemoglobin to normal or near-normal levels using the minimum effective dose. In general, if blood glucose is temporarily uncontrolled in patients whose blood glucose was controlled with diet alone, short-term administration of this medicine may be sufficient to achieve an adequate effect. This medicine may be used in patients with moderate renal impairment at stage 3a (creatinine clearance [CrCl] 45≤~<60ml/min or glomerular filtration rate (GFR) 45≤~<60mL/min/1.73㎡) who have no other symptoms that may increase the risk of lactic acidosis, with the following dose adjustment. - Start with 500mg or 850mg once a day. The maximum daily dose is 1000mg, administered in 2 divided doses. Renal function should be monitored closely every 3-6 months. If creatinine clearance or glomerular filtration rate falls below 45ml/min or 45ml/min/1.73㎡, respectively, administration of this medicine must be stopped immediately.
Child dose
Children 10 years and older or adolescents who are still growing: The usual initial dose is 500 milligrams once a day, administered during or after a meal. Measure blood glucose after one week and adjust the dose. Gastrointestinal adverse effects may improve with gradual dose increases. The maximum daily dose is 2000mg. Divide this dose into 2~3 doses.

Ingredients

Manufacturer
Donggu Bio Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of type 2 diabetes mellitus

  • Type 2 Diabetes
View approved original text

This medication is used for patients with Type 2 diabetes whose blood sugar is difficult to control with diet and exercise alone, particularly for overweight adults and children and adolescents aged 10 and older. It helps manage blood sugar either alone or in combination with other oral hypoglycemic agents or insulin, effectively regulating blood sugar levels to assist in managing diabetes.

How to take

Adult dose

The dose should be determined individually based on drug efficacy and tolerability and should not exceed the recommended maximum daily dose. This medicine must be started at a low dose to reduce gastrointestinal adverse reactions and identify the minimum dose required for adequate glycemic control. Administer 500mg per dose, 2~3 times a day, with meals. Increase the dose gradually by 500mg each week; when administering up to 2000mg, the dose is usually divided into 2 doses, in the morning and evening. If administering more than 2000mg, divide the dose into 3 doses per day and take with meals; up to a maximum of 2550mg per day may be administered. At initiation of treatment and during dose adjustment, measure fasting blood glucose to assess the response to this medicine and determine the minimum effective dose. Measure blood glycated hemoglobin approximately every 3 months. The goal of treatment with this medicine, whether administered as monotherapy or in combination with a sulfonylurea or insulin, is to reduce fasting blood glucose and blood glycated hemoglobin to normal or near-normal levels using the minimum effective dose. In general, if blood glucose is temporarily uncontrolled in patients whose blood glucose was controlled with diet alone, short-term administration of this medicine may be sufficient to achieve an adequate effect. This medicine may be used in patients with moderate renal impairment at stage 3a (creatinine clearance [CrCl] 45≤~<60ml/min or glomerular filtration rate (GFR) 45≤~<60mL/min/1.73㎡) who have no other symptoms that may increase the risk of lactic acidosis, with the following dose adjustment. - Start with 500mg or 850mg once a day. The maximum daily dose is 1000mg, administered in 2 divided doses. Renal function should be monitored closely every 3-6 months. If creatinine clearance or glomerular filtration rate falls below 45ml/min or 45ml/min/1.73㎡, respectively, administration of this medicine must be stopped immediately.

Child dose

Children 10 years and older or adolescents who are still growing: The usual initial dose is 500 milligrams once a day, administered during or after a meal. Measure blood glucose after one week and adjust the dose. Gastrointestinal adverse effects may improve with gradual dose increases. The maximum daily dose is 2000mg. Divide this dose into 2~3 doses.

Precautions

This medication can cause severe lactic acidosis or hypoglycemia, so caution is needed. It should not be used in patients with moderately severe or worse renal impairment, those in a state of dehydration, severe infection, heart failure, or other acute conditions. If undergoing examinations using iodinated contrast media, administration of this medication should be temporarily suspended until renal function is confirmed normal before resuming. It should not be administered to patients with a history of allergic reactions to this medication, Type 1 diabetes, or acute metabolic acidosis. Temporary discontinuation of this medication may be necessary in cases where oral intake is difficult due to preoperative or postoperative conditions, severe infections, or trauma. Caution is required for patients with liver dysfunction, respiratory function decline, or excessive alcohol intake. Irregular meals, excessive exercise, and interactions with other medications can increase the risk of lactic acidosis and hypoglycemia, so it should be administered with care. Lactic acidosis is very rare but can be fatal; therefore, immediate consultation with a doctor is necessary if symptoms such as malaise, muscle pain, difficulty breathing, or abdominal pain occur. Gastrointestinal symptoms are common during early treatment and can be alleviated by taking the medication with meals or gradually increasing the dosage. This medication is primarily excreted through the kidneys, so regular kidney function tests should be performed before and during treatment, and administration should be discontinued if kidney function declines. In situations where blood sugar control becomes difficult, such as illness or surgery, temporary discontinuation of medication may be necessary, and insulin therapy may be required. Excessive alcohol consumption should be avoided as it can increase the risk of side effects from this medication. Vitamin B12 deficiency may occur, necessitating regular blood tests for monitoring. During pregnancy, careful consideration of the effects on the fetus is necessary, and administration should be avoided if there is a risk of placental dysfunction or preeclampsia. This medication is secreted into breast milk, so careful decisions regarding breastfeeding and drug treatment discontinuation should be made. Elderly patients are at higher risk of renal impairment; therefore, treatment should start at the minimum dosage, and regular kidney function tests are necessary. In case of overdose, blood dialysis may be beneficial, and immediate contact with a healthcare facility is required. Given the potential for numerous drug-drug interactions, if taking other medications, consult with a physician or pharmacist. While taking this medication, it is important to regularly monitor blood sugar levels and kidney function to confirm treatment efficacy and side effects. When administering to children or adolescents, careful observation of growth and development is necessary. This medication assists in blood sugar control without weight gain, but maintaining a healthy diet and regular exercise is recommended during treatment.

Side effects

  • Lactic acidosis
  • diarrhea
  • nausea
  • vomiting
  • abdominal distension
  • loss of appetite
  • dyspepsia
  • constipation
  • abdominal pain
  • metallic taste
Show 7 more
  • rash
  • anemia
  • leukopenia
  • thrombocytopenia
  • vitamin B12 deficiency
  • liver dysfunction
  • severe delayed hypoglycemia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air and moisture, so it should be stored in a sealed container. The storage temperature should be kept at room temperature between 1 and 30 degrees Celsius. Proper storage conditions will help maintain the drug's efficacy for a longer period.

Appearance and packaging

Appearance

White round film-coated tablet

Package unit

30 tablets/bottle, 500 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.